Co-occurring clonal hematopoiesis exhibits strong selection and high leukemia risk
Abstract
Abstract Clonal hematopoiesis of indeterminate potential (CHIP) and mosaic chromosomal alterations (mCAs) are two types of clonal hematopoiesis (CH) associated with hematological parameters and malignancy risk. Here we show, in genomic data from 546,090 biobank participants, that co-occurring CH (≥2 CH mutations detected) is present in 1.6% of cancer-free individuals and shows strong evidence for selection (up to 804x enrichment). Co-occurrence is more frequent in those with a prior cancer (3.6%), suggesting treatment-induced selection. Acquisition of CHIP usually precedes mCAs with co-occurrences manifesting stronger phenotypic disruptions in telomere attrition and hematologic parameters than component CH events. Individuals with co-occurring CH have pronounced elevations in risk of myeloid and lymphoid malignancies (HRs>40), particularly when CHIP and mCAs overlap genomically. Our findings indicate CH co-occurrences are selected for in the aging population and identify CH clones with notable implications for future malignancy risk.
Article Details
Authors (61)
Kara M. Barnao
Aubrey K. Hubbard
Irenaeus C. C. Chan
Weiyin Zhou
Yasminka A. Jakubek
Giulio Genovese
Wendy S. W. Wong
Rebecca L. Kelly
Corey D. Young
Derek W. Brown
Wen-Yi Huang
Neal D. Freedman
Division of Cancer Control and Population Sciences National Cancer Institute Rockville Maryland USA
Kristine Jones
Amy Hutchinson
Belynda Hicks
Duc Tran
Institute of Physics, Johannes Gutenberg-University Mainz, Mainz, Germany.
Donna Arnett
Kathleen C. Barnes
Joshua C. Bis
Eric Boerwinkle
Jennifer A. Brody
April P. Carson
Daniel I. Chasman
Michael H. Cho
Channing Division of Network Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.
Pinkal Desai
Margaret F. Doyle
Myriam Fornage
Xiuqing Guo
Nancy Heard-Costa
Chobanian & Avedisian School of Medicine, Boston University, Boston, MA, USA.
Marguerite Ryan Irvin
Andrew D. Johnson
Sharon L. R. Kardia
Charles Kooperberg
Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Daniel Levy
Population Sciences Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Joshua P. Lewis
Yun Li
Ruth J. F. Loos
Taralynn M. Mack
Rasika A. Mathias
Braxton D. Mitchell
Kari E. North
Nathan Pankratz
Patricia A. Peyser
Michael H. Preuss
Bruce M. Psaty
Laura M. Raffield
Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Susan Redline
Stephen S. Rich
Department of Genome Sciences, School of Medicine, University of Virginia, Charlottesville, VA, USA.
Jerome I. Rotter
Edwin K. Silverman
Channing Division of Network Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.
Albert V. Smith
Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Jennifer A. Smith
Adrienne Stilp
Yin Cao
Paul Scheet
Alexander P. Reiner
Alexander G. Bick
Stephen J. Chanock
Paul L. Auer
Kelly L. Bolton
Mitchell J. Machiela